ABL Diagnostics
Develops molecular diagnostic solutions for managing infectious diseases.
ABLD | PA
Overview
Corporate Details
- ISIN(s):
- FR0000063034 (+1 more)
- LEI:
- 9695002UO0UHM0VKRH38
- Country:
- France
- Address:
- 72 ROUTE DE THIONVILLE, 57140 WOIPPY
- Website:
- https://www.ablsa.com
- Sector:
- Manufacturing
Description
ABL Diagnostics is a molecular diagnostics company that develops and commercializes solutions for the diagnosis and management of infectious diseases. The company's offerings include in-vitro diagnostic (IVD) medical devices, PCR-based assays such as the UltraGene product line, and integrated software for data analysis and laboratory automation. ABL Diagnostics also provides the Nadis® electronic medical record (EMR) system for clinical data management. The company specializes in genotyping and sequencing technologies, with a primary focus on monitoring drug resistance in viral infections like HIV and viral hepatitis.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-12-19 08:00 |
Inside Information / Other news releases
|
English | 266.5 KB | ||
| 2025-12-19 08:00 |
Informations privilégiées / Autres communiqués
|
French | 280.0 KB | ||
| 2025-12-05 17:00 |
Inside Information / Operations of the issuer (acquisitions, sales...)
|
English | 183.5 KB | ||
| 2025-12-05 17:00 |
Informations privilégiées / Opérations de l'émetteur (acquisitions, cessions...)
|
French | 228.7 KB | ||
| 2025-11-14 08:00 |
Informations privilégiées / Autres communiqués
|
French | 188.9 KB | ||
| 2025-11-14 08:00 |
Inside Information / Other news releases
|
English | 189.6 KB | ||
| 2025-10-22 18:00 |
Inside Information / Other news releases
|
English | 202.5 KB | ||
| 2025-10-22 18:00 |
Informations privilégiées / Autres communiqués
|
French | 203.1 KB | ||
| 2025-10-16 18:00 |
Inside Information / Other news releases
|
English | 233.2 KB | ||
| 2025-10-16 18:00 |
Informations privilégiées / Autres communiqués
|
French | 212.7 KB | ||
| 2025-10-01 18:00 |
Rapports financiers et d'audit semestriels/examens réduits / Modalités de mise …
|
French | 201.1 KB | ||
| 2025-10-01 18:00 |
Rapports financiers et d'audit semestriels/examens réduits / Rapport financier …
|
French | 2.4 MB | ||
| 2025-07-03 18:00 |
Acquisition ou cession des actions de l'émetteur / Information relative au cont…
|
French | 399.0 KB | ||
| 2025-06-25 18:13 |
Acquisition ou cession des actions de l'émetteur / Descriptif du programme de r…
|
French | 128.9 KB | ||
| 2025-05-07 18:40 |
Rapports financiers et d'audit annuels / Rapport financier annuel
|
French | 4.5 MB |
Automate Your Workflow. Get a real-time feed of all ABL Diagnostics filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for ABL Diagnostics
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for ABL Diagnostics via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
